BioCentury
ARTICLE | Clinical News

Hollis-Eden preclinical data

February 2, 2009 8:00 AM UTC

In rat models of obesity induced metabolic disorders, oral Triolex produced complete normalization of fasting and fed blood glucose levels, improved insulin sensitivity, reduced concentrations of pyru...